Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves comparing the patient's risk of stroke to the risk of hemorrhage from medication use.